Refine by
Autoimmune Articles & Analysis
150 news found
It opens the door to a deeper understanding of inflammatory pathways and the diverse roles neutrophils play in chronic diseases, autoimmunity, and cancer. By improving the ability to detect and monitor these cells, researchers are creating opportunities for more precise diagnostic tools and innovative therapeutic strategies. ...
Therefore, flow cytometry is widely used in clinical diagnosis and medical research, such as tumor-associated diseases, autoimmune diseases, cardiovascular diseases, inflammatory infections and infectious diseases, providing higher clinical value for differential diagnosis, treatment monitoring and condition assessment. ...
Insights into this paradigm are expected to link the regulation of pathways to the restoration of immune homeostasis for the treatment of a wide range of diseases, including infectious diseases, autoimmune disorders, allograft rejection and malignancies. To help scientists better understand the regulation and role of mTOR in metabolic regulation and to address some of the major ...
This critical information holds immense potential in unraveling immune responses, gaining insights into autoimmune diseases, advancing cancer immunotherapy, and propelling vaccine development. ...
This empowers researchers and pharmaceutical entities to tailor antibody therapies for an extensive array of diseases, ranging from cancer to autoimmune disorders. The Antibody Drug Design Services streamline development timelines, concurrently optimizing costs and increasing the likelihood of success. ...
Antibody-based therapies have witnessed unprecedented success in treating a wide array of diseases, from cancer to autoimmune disorders. However, the traditional antibody discovery process is labor-intensive, time-consuming, and costly. ...
About Chronic Kidney Disease in Type 1 Diabetes T1D is a chronic autoimmune disorder characterized by destruction of pancreatic beta cells leading to insulin deficiency and requiring lifelong insulin treatment. ...
ByBayer AG
Furthermore, Creative Diagnostics' services cover a variety of diseases, including cardiovascular diseases, oncology, inflammatory and autoimmune diseases, infectious diseases, and psychiatric disorders. Notably, it also provides assay development services for biomarkers, including proteins, nucleic acids, carbohydrates, and lipids, as well as building diagnostic kits that access ...
With its advanced technological platform and cutting-edge sequencing and analysis algorithms, this service is designed to accurately and efficiently identify biomarkers that can be used to diagnose or predict the onset of a wide range of diseases, including infectious diseases, cancer, and autoimmune disorders. With its ability to identify microbial biomarkers that are associated ...
There are more than 100 kinds of diseases related to HLA, involving autoimmune diseases, immunodeficiency diseases, allergic diseases, infectious diseases, metabolic diseases, and so on. ...
While IVS currently focuses on applications of the LITATM in cardiac safety and discovery projects, IVS has plans for developing a wide range of useful applications in treatment development for regenerative medicine, cancer, autoimmune disorders, and a wide range of rare diseases. Our unique combination of tissue engineering technology with assay automation and sample ...
Biolojic Design also has partnerships with Nektar Therapeutics for the development of antibodies against autoimmune diseases and Eli Lilly for the development of antibodies that fight diabetes. ...
Dr. Ali Tinazli's post at the Forbes magazine about "History Of Health Technologies And Meaningful Change In The Era Of Health 4.0" The medicine in ancient Egypt is some of the oldest in history. Although rudimentary, it was already highly personalized and with exclusive access. During the Renaissance—one of the most remarkable ages of humankind—medicine ...
Bioactive lipids are consistently involved in chronic inflammation for pathological characterization, such as cancer, diabetes, atherosclerosis, asthma, inflammatory bowel disease, as well as autoimmune and neurodegenerative disorders. “With years of experience in lipid chemistry, Alfa Chemistry now provides a full range of fatty acids and esters, glycerides, fatty ...
Gene expression and therapy involves the introduction of foreign nucleic acids into target cells to modify or compensate for gene defects, thereby treating diseases such as cancer, diabetes, autoimmune diseases, and infectious diseases. However, when exposed nucleic acids are removed fast, resulting in low rates of nonspecific biodistribution and cellular internalization, ...
Creative BioMart, a biotechnology company that offers a wide range of solutions dedicated to helping researchers and pharmaceutical companies discover and develop novel drugs in the treatment of cancer, autoimmune diseases, etc., now offers MHC solutions for cell therapy and vaccine development. ...
Jubilant Therapeutics Inc., a clinical stage biopharmaceutical company developing precision oral medicines with enhanced therapeutic index to serve genetically defined patients suffering from cancer and autoimmune diseases, today announced that Syed Kazmi, Chief Executive Officer, will be making a business update presentation and meeting with institutional investors at the ...
BioPharma: Microbiome therapeutics, anti-microbial resistance, personalised/stratified medicine, therapeutics for gastrointestinal and infectious diseases, immuno-oncology/autoimmune disease and metabolic health. Anthony Finbow, CEO, Eagle Genomics, said: “We are the pre-eminent platform business using next-generation graph technology and network science to drive the ...
By doing so we’ll improve our ability to create new biologics from natural proteins, and bring new therapeutics to patients across a wide range of indications from infectious disease vaccines and therapeutics, to rheumatology, to rare disease, and to autoimmune disorders. About Cyrus Biotechnology Cyrus Biotechnology is a pre-clinical-stage biotech company combining ...
The analysis was carried out by researchers at Lund University and provides additional support for the application of the therapeutic diabetes vaccine Diamyd® to prevent or delay clinical type 1 diabetes, and aligns with the rationale of the VINNOVA-financed ASSET project (AI for Sustainable Prevention of Autoimmunity in the Society) coordinated by Diamyd Medical. ...